Product Information
DEXLANSOPRAZOLE DR 30 MG CAP is a generic product labeled by Endo USA Inc., priced at $3.9664 per EA under NDC 49884014711. Its NADAC has been published 163 times since Jul 12, 2023.
FDA first approved this application on Apr 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Endo USA Inc.NDC
49884014711
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEXLANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202294FDA Approved
4/19/2017
TE Code
AB
On Market Since
6/10/2023
Pharmacological Classes
Price Statistics
The NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has been published 163 times since Jul 12, 2023, and over the history we have for it it has declined 46.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9664 per EA |
|---|---|
| All-time high | $7.6443 (Feb 14, 2024) |
| All-time low | $3.8700 (Jul 17, 2024) |
| 52-week high | $4.8639 |
| 52-week low | $3.9664 |
| Median price | $4.8365 |
| Average price | $5.2969 |
| Largest weekly change | +32.8% (Aug 21, 2024) |
| Weeks tracked | 163 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXLANSOPRAZOLE DR 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXLANSOPRAZOLE DR 30 MG CAP, manufactured by Endo USA Inc., is $3.9664 per EA (NDC 49884014711), effective Aug 19, 2026.
How has the price of DEXLANSOPRAZOLE DR 30 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has declined 46.3%. It has been tracked across 163 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for DEXLANSOPRAZOLE DR 30 MG CAP?
Since Jul 12, 2023, the NADAC for DEXLANSOPRAZOLE DR 30 MG CAP has ranged from a low of $3.8700 (Jul 17, 2024) to a high of $7.6443 (Feb 14, 2024), with a median of $4.8365 per EA.
Are there cheaper alternatives to DEXLANSOPRAZOLE DR 30 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXLANSOPRAZOLE DR 30 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXLANSOPRAZOLE DR 30 MG CAP?
DEXLANSOPRAZOLE DR 30 MG CAP (NDC 49884014711) is labeled by Endo USA Inc., and CMS classifies it as a generic product.